Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_assertion description "[We conclude that lenalidomide has the potential to induce sustained hematological and cytogenetic remissions in the poor prognosis MDS subgroup of del(5q31) patients with complex chromosomal anomalies and that this is likely to improve overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_assertion evidence source_evidence_literature NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_assertion SIO_000772 15891887 NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_assertion wasDerivedFrom befree-2016 NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_assertion wasGeneratedBy ECO_0000203 NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.
- befree-2016 importedOn "2016-02-19" NP494591.RA2xiV2ROUis6WGnCReEIsE5gv6QcOLz3tcBt2OoJJL-U130_provenance.